Eugene C. Ho

  • Citations Per Year
Learn More
We used novel 3'-monoiodothyronine sulfate (3'-T1S) and 3,3',5-triiodothyroacetic acid sulfate (TriacS) RIAs to characterize sulfation pathways in fetal thyroid hormone metabolism. 3'-T1S and TriacS levels were measured in serum samples obtained from fetal (n = 21, 94-145 d gestational age), newborn (NB, n = 5), and adult sheep (AD, n = 5) as well as from(More)
OBJECTIVE To test whether the serial measurement of maternal levels of compound W, a 3,3'-diiodothyronine sulfate cross-reactive substance, can serve as a potential indicator of fetal thyroid function in pregnant women receiving antithyroid medication. METHODS Compound W was measured repeatedly in serum of pregnant women with hyperthyroidism treated with(More)
Compound W, a 3,3'-diiodothyronine sulfate (T2S) cross-reactive material in maternal serum, was found to be useful as a marker for fetal hypothyroidism. In the present report, we explored its biochemical properties and studied its concentrations in cord and in maternal serum obtained from various gestational periods and at term from different continents.(More)
Received 10/24/2005; revised 11/4/2005; accepted 11/10/2005. For correspondence or reprints contact: Wen-Sheng Huang, M.D. Department of Nuclear Medicine, Tri-Service General Hospital. 325 Section 2, Cheng-Kung Road, Neihu, Taipei 114, Taiwan. Tel: (886)2-87927374, Fax: (886)2-87927217, Email: Like many malignancies, increased(More)
  • 1